Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Scleroderma, myositis and related syndromes - clinical aspects and treatment
FRI0496 An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis (SSC) Patients Treated with Paquinimod (ABR-215757)
Compose a Response to This Article
Other responses
No responses have been published for this article.